Choosing sample size for a clinical trial using decision analysis
From MaRDI portal
Publication:2813906
DOI10.1093/biomet/90.4.923zbMath1436.62523OpenAlexW2157986324MaRDI QIDQ2813906
Donald A. Berry, Fusheng Su, Yi. Cheng
Publication date: 27 June 2016
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biomet/90.4.923
decision theoryBayescentral limit theoremmartingale convergence theoremoptimal sample sizeclinical trial in stagesgroup sequential treatment allocation
Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian problems; characterization of Bayes procedures (62C10)
Related Items (9)
Determination of the optimal sample size for a clinical trial accounting for the population size ⋮ Admissible treatment rules for a risk-averse planner with experimental data on an innovation ⋮ Response-adaptive randomization in clinical trials: from myths to practical considerations ⋮ Quasi-optimal Bayesian procedures of many hypotheses testing ⋮ BANDIT STRATEGIES EVALUATED IN THE CONTEXT OF CLINICAL TRIALS IN RARE LIFE-THREATENING DISEASES ⋮ Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design ⋮ Bayesian statistics and the efficiency and ethics of clinical trials ⋮ Closed form expressions for Bayesian sample size ⋮ Treatment Choice With Trial Data: Statistical Decision Theory Should Supplant Hypothesis Testing
This page was built for publication: Choosing sample size for a clinical trial using decision analysis
